Convergence Investment Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,728
| Closed | -$270K | – | 285 |
|
|
2020
Q4 | $270K | Sell |
1,728
-7,869
| -82% | -$1.23M | 0.14% | 146 |
|
|
2020
Q3 | $1.1M | Buy |
9,597
+547
| +6% | +$62.6K | 0.38% | 95 |
|
|
2020
Q2 | $1.02M | Buy |
+9,050
| New | +$1.02M | 0.35% | 98 |
|
|
2019
Q4 | – | Sell |
-11,997
| Closed | -$1.18M | – | 337 |
|
|
2019
Q3 | $1.18M | Buy |
+11,997
| New | +$1.18M | 0.33% | 112 |
|
|
2018
Q2 | – | Sell |
-575
| Closed | -$64K | – | 992 |
|
|
2018
Q1 | $64K | Buy |
+575
| New | +$64K | 0.01% | 407 |
|
|
2014
Q4 | – | Sell |
-5,135
| Closed | -$851K | – | 439 |
|
|
2014
Q3 | $851K | Sell |
5,135
-3,238
| -39% | -$537K | 0.12% | 262 |
|
|
2014
Q2 | $1.31M | Buy |
+8,373
| New | +$1.31M | 0.17% | 189 |
|